Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

[Astrocytes in Huntington's chorea: accomplice or guilty of the neuronal death?].

Liévens JC, Birman S.

Med Sci (Paris). 2007 Oct;23(10):845-9. Review. French.

2.

[Huntington's disease: intracellular signaling pathways and neuronal death].

Humbert S, Saudou F.

J Soc Biol. 2005;199(3):247-51. Review. French.

PMID:
16471265
3.

Huntington's disease and Group I metabotropic glutamate receptors.

Ribeiro FM, Pires RG, Ferguson SS.

Mol Neurobiol. 2011 Feb;43(1):1-11. doi: 10.1007/s12035-010-8153-1. Epub 2010 Dec 9. Review.

PMID:
21153060
4.

The therapeutic potential of G-protein coupled receptors in Huntington's disease.

Dowie MJ, Scotter EL, Molinari E, Glass M.

Pharmacol Ther. 2010 Nov;128(2):305-23. doi: 10.1016/j.pharmthera.2010.07.008. Epub 2010 Aug 11. Review.

PMID:
20708032
5.

Huntington's disease: from molecular pathogenesis to clinical treatment.

Ross CA, Tabrizi SJ.

Lancet Neurol. 2011 Jan;10(1):83-98. doi: 10.1016/S1474-4422(10)70245-3. Review.

PMID:
21163446
7.

Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies.

Borrell-Pagès M, Zala D, Humbert S, Saudou F.

Cell Mol Life Sci. 2006 Nov;63(22):2642-60. Review.

PMID:
17041811
8.

Cellular and molecular mechanisms involved in the selective vulnerability of striatal projection neurons in Huntington's disease.

Pérez-Navarro E, Canals JM, Ginés S, Alberch J.

Histol Histopathol. 2006 Nov;21(11):1217-32. Review.

PMID:
16874665
9.

Huntingtin and its role in neuronal degeneration.

Li SH, Li XJ.

Neuroscientist. 2004 Oct;10(5):467-75. Review.

PMID:
15359012
10.

Mutant huntingtin can paradoxically protect neurons from death.

Zuchner T, Brundin P.

Cell Death Differ. 2008 Mar;15(3):435-42. Epub 2007 Nov 2. Review.

11.

Protein aggregation in Huntington's disease.

Hoffner G, Djian P.

Biochimie. 2002 Apr;84(4):273-8. Review.

PMID:
12106904
12.

Huntington's disease: the challenge for cell biologists.

Tobin AJ, Signer ER.

Trends Cell Biol. 2000 Dec;10(12):531-6. Review.

PMID:
11121745
13.

Aging and neurodegeneration. Molecular mechanisms of neuronal loss in Huntington's disease.

Lee ST, Kim M.

Mech Ageing Dev. 2006 May;127(5):432-5. Epub 2006 Mar 9. Review.

PMID:
16527334
14.

Apoptosis in Huntington's disease.

Hickey MA, Chesselet MF.

Prog Neuropsychopharmacol Biol Psychiatry. 2003 Apr;27(2):255-65. Review.

PMID:
12657365
15.

Targeting glial cells to elucidate the pathogenesis of Huntington's disease.

Hsiao HY, Chern Y.

Mol Neurobiol. 2010 Jun;41(2-3):248-55. doi: 10.1007/s12035-009-8097-5. Epub 2010 Jan 28. Review.

PMID:
20107928
16.

Oxidative stress in Huntington's disease.

Browne SE, Ferrante RJ, Beal MF.

Brain Pathol. 1999 Jan;9(1):147-63. Review.

PMID:
9989457
17.

Gene-environment interactions, neuronal dysfunction and pathological plasticity in Huntington's disease.

van Dellen A, Grote HE, Hannan AJ.

Clin Exp Pharmacol Physiol. 2005 Dec;32(12):1007-19. Review.

PMID:
16445565
18.

Huntington's disease: clinical characteristics, pathogenesis and therapies.

Nakamura K, Aminoff MJ.

Drugs Today (Barc). 2007 Feb;43(2):97-116. Review.

PMID:
17353947
19.

Huntington's disease: From molecular basis to therapeutic advances.

Krobitsch S, Kazantsev AG.

Int J Biochem Cell Biol. 2011 Jan;43(1):20-4. doi: 10.1016/j.biocel.2010.10.014. Epub 2010 Nov 4. Review.

PMID:
21056115
20.

The early cellular pathology of Huntington's disease.

Li XJ.

Mol Neurobiol. 1999 Oct-Dec;20(2-3):111-24. Review.

PMID:
10966117
Items per page

Supplemental Content

Write to the Help Desk